Subal Pharmaceuticals Private Limited

Subal Pharmaceuticals Private Limited - pharma in Chandrapur, Maharashtra, India. FY 2026 financials & compliance.
CIN U24304MH2017PTC290952 Incorporated 08 February 2017 ROC Nagpur HQ Chandrapur, Maharashtra, India
Active Private Limited Company pharma
Data last updated
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
9 yrs
Est. 2017
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date
Last AGM
30 Sep 2025
Annual general meeting
Company status
Active
MCA master data
Registrar
Nagpur
ROC office

About Subal Pharmaceuticals Private Limited

Data last updated:

Subal Pharmaceuticals Private Limited is a private limited company based in Chandrapur, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 08 February 2017 and has been in existence for over 9 years.

The company is registered with the Registrar of Companies (ROC), Nagpur, under CIN U24304MH2017PTC290952.

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rajasri Milind Wasalwar and Milind Wasalwar Laxamanrao.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Rani Raakuwar Shale Jawal Mahesh Nagar Tukum, Chandrapur, Maharashtra, India – 442401.

The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of Subal Pharmaceuticals Private Limited
CIN U24304MH2017PTC290952
Registration Number 290952
Incorporation Date 08 February 2017
ROC Nagpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    Rani Raakuwar Shale Jawal Mahesh Nagar Tukum, Chandrapur, Maharashtra, India – 442401
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Subal Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Subal Pharmaceuticals Private Limited report

Financials, compliance, directors, charges, ownership and filings for Subal Pharmaceuticals Private Limited in one report.

Financials from FY 2017 Directors & ownership Charges & compliance

Financials of Subal Pharmaceuticals Private Limited FY 2025 filings available

Financial Statement Summary of Subal Pharmaceuticals Private Limited

MetricsFY 2021-22FY 2020-21FY 2019-20FY 2018-19FY 2017-18
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA••••••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)••••••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Subal Pharmaceuticals Private Limited

MetricsFY 2021-22FY 2020-21FY 2019-20FY 2018-19FY 2017-18
Profitability
EBITDA Margin••••••••••••••••••••
Net Profit Margin••••••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Subal Pharmaceuticals are in the company report.

Premium access

Financial statements from FY 2017

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Board of Directors of Subal Pharmaceuticals Private Limited

Subal Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Rajasri Milind WasalwarDirector27 Jul 20224 Years 2 MonthsCurrent
Milind Wasalwar LaxamanraoDirector08 Feb 20179 Years 8 MonthsCurrent

Ownership and Shareholding of Subal Pharmaceuticals Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Subal Pharmaceuticals Private Limited

Subal Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Subal Pharmaceuticals Private Limited

Employment history and EPFO contributions of people linked to Subal Pharmaceuticals.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Subal Pharmaceuticals Private Limited

Subal Pharmaceuticals Private Limited has 8 board changes on record since 2017: 5 appointments and 3 cessations. The latest: Rajasri Milind Wasalwar was appointed as Director on 27 Jul 2022.

AGM
Subal Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Subal Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Nagpur.
Appointed
Rajasri Milind Wasalwar was appointed as Director.
Ceased
Ramana Venkat Akkaladevi ceased to be Director.
Ceased
Kiran Bhaiyyaji Gadivan ceased to be Director.
Ceased
Lili Uday Sahu ceased to be Director.
Appointed
Ramana Venkat Akkaladevi was appointed as Director.
Appointed
Kiran Bhaiyyaji Gadivan was appointed as Director.
Appointed
Lili Uday Sahu was appointed as Director.
Appointed
Milind Wasalwar Laxamanrao was appointed as Director.
Incorporation
08 Feb 2017
Subal Pharmaceuticals Private Limited was registered on 08 Feb 2017 with Roc Nagpur & aged 9 years 8 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Subal Pharmaceuticals Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Subal Pharmaceuticals Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Subal Pharmaceuticals Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Subal Pharmaceuticals Private Limited

Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Subal Pharmaceuticals Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Subal Pharmaceuticals Private Limited

Subal Pharmaceuticals is an active private limited company based in Chandrapur, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 08 February 2017 (9+ years old) and is registered under CIN U24304MH2017PTC290952.

Subal Pharmaceuticals has 2 current directors:

The CIN (Corporate Identification Number) of Subal Pharmaceuticals is U24304MH2017PTC290952. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Subal Pharmaceuticals was incorporated on 08 February 2017, making it 9+ years old. It is registered with the Registrar of Companies, Nagpur.

Rajasri Milind Wasalwar was appointed as Director on 27 Jul 2022. Ramana Venkat Akkaladevi ceased to be Director on 27 Jul 2022. Kiran Bhaiyyaji Gadivan ceased to be Director on 22 Feb 2017. Subal Pharmaceuticals has 8 board changes on record in total.

The registered office of Subal Pharmaceuticals is at Rani Raakuwar Shale Jawal Mahesh Nagar Tukum, Chandrapur, Maharashtra, India – 442401.

Subal Pharmaceuticals has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.

Subal Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.

No. Subal Pharmaceuticals is not listed on any stock exchange. It is an unlisted company.

The compliance status of Subal Pharmaceuticals is compliant as of 18 August 2026. The company is actively filing with the Registrar of Companies.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available